価格表

在庫・価格 : 2025年04月26日 23時22分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-IL-10 Receptor β, Human, Goat-Poly
データシート※最新のデータシートでない場合があります
AF874 RSDアールアンドディー システムズ
R&D Systems, Inc.
100 μg ¥105,000
(未発注)
追加

在庫・価格 : 2025年04月26日 23時22分 現在

Anti-IL-10 Receptor β, Human, Goat-Poly

  • 商品コード:AF874
  • メーカー:RSD
  • 包装:100μg
  • 価格: ¥105,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Sheppard P et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 2003 Jan;4(1):63-8
Sheppard P et al
2003/01/01
human 293 embryonic kidney cells PubMed
2 Heuze-Vourc'h N et al. Abnormal interleukin 10Ralpha expression contributes to the maintenance of elevated cyclooxygenase-2 in non-small cell lung cancer cells. Cancer Res. 2003 Feb;63(4):766-70
Heuze-Vourc'h N et al
2003/01/01
Application: Flow Cytometry, Sample Type: Whole Cells PubMed
3 Sheikh F et al. Cutting edge: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2. J. Immunol. 2004 Feb;172(4):2006-10
Sheikh F et al
2004/01/01
Application: Neutralization, Sample Type: Whole Cells PubMed
4 Meager A et al. Biological activity of interleukins-28 and -29: comparison with type I interferons. Cytokine 2005 Jul;31(2):109-18
Meager A et al
2005/01/01
Species: Human, Application: Neutralization, Sample type: Whole Cells PubMed
5 Witte K et al. Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines. Genes Immun. 2009 Dec;10(8):7
Witte K et al
2009/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
6 Chandra PK et al. HCV infection selectively impairs type I but not type III IFN signaling. Am. J. Pathol. 2014 Jan;184(1):214-29
Chandra PK et al
2014/01/01
Application: Flow Cytometry, Sample Type: whole cells PubMed
7 Friborg J et al. Impairment of type I but not type III IFN signaling by hepatitis C virus infection influences antiviral responses in primary human hepatocytes. PLoS ONE 2015;10(3):e0121734
Friborg J et al
2015/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
8 Sullivan KD et al. Trisomy 21 consistently activates the interferon response. Elife 2016 Jul;5
Sullivan KD et al
2016/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
9 Obajemu AA et al. IFN-λ4 Attenuates Antiviral Responses by Enhancing Negative Regulation of IFN Signaling. J. Immunol. 2017 12;199(11):3808-3820
Obajemu AA et al
2017/01/01
Species: Human, Applications: Neut PubMed
  • No.: 1
  • 文献情報:
    Sheppard P et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 2003 Jan;4(1):63-8
    Sheppard P et al
    2003/01/01
  • 備考:
    human 293 embryonic kidney cells
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Heuze-Vourc'h N et al. Abnormal interleukin 10Ralpha expression contributes to the maintenance of elevated cyclooxygenase-2 in non-small cell lung cancer cells. Cancer Res. 2003 Feb;63(4):766-70
    Heuze-Vourc'h N et al
    2003/01/01
  • 備考:
    Application: Flow Cytometry, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Sheikh F et al. Cutting edge: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2. J. Immunol. 2004 Feb;172(4):2006-10
    Sheikh F et al
    2004/01/01
  • 備考:
    Application: Neutralization, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Meager A et al. Biological activity of interleukins-28 and -29: comparison with type I interferons. Cytokine 2005 Jul;31(2):109-18
    Meager A et al
    2005/01/01
  • 備考:
    Species: Human, Application: Neutralization, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Witte K et al. Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines. Genes Immun. 2009 Dec;10(8):7
    Witte K et al
    2009/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Chandra PK et al. HCV infection selectively impairs type I but not type III IFN signaling. Am. J. Pathol. 2014 Jan;184(1):214-29
    Chandra PK et al
    2014/01/01
  • 備考:
    Application: Flow Cytometry, Sample Type: whole cells
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Friborg J et al. Impairment of type I but not type III IFN signaling by hepatitis C virus infection influences antiviral responses in primary human hepatocytes. PLoS ONE 2015;10(3):e0121734
    Friborg J et al
    2015/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Sullivan KD et al. Trisomy 21 consistently activates the interferon response. Elife 2016 Jul;5
    Sullivan KD et al
    2016/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Obajemu AA et al. IFN-λ4 Attenuates Antiviral Responses by Enhancing Negative Regulation of IFN Signaling. J. Immunol. 2017 12;199(11):3808-3820
    Obajemu AA et al
    2017/01/01
  • 備考:
    Species: Human, Applications: Neut
  • 参照:
    PubMed